Document:

EX-10.13

 Exhibit 10.13 

VIEW, INC. 
 2021 CHIEF
EXECUTIVE OFFICER INCENTIVE PLAN 
 NOTICE OF STOCK OPTION GRANT 

Participant Name: Rao Mulpuri 

You have been granted an Option to purchase Common Stock, subject to the terms and conditions of this Notice of Stock Option Grant (the
“Notice of Grant”), the View, Inc. 2021 Chief Executive Officer Incentive Plan (the “Plan”) and the attached Stock Option Agreement, including Exhibit A attached hereto (the “Award
Agreement”), as set forth below. Unless otherwise defined herein, the terms used in this Notice of Grant shall have the meanings defined in the Plan. 
  

			
	Date of Grant:	  	March 8, 2021  
		
	Vesting Commencement Date:	  	March 8, 2021  
		
	Exercise Price per Share:	  	USD $ 10.00    
		
	Total Number of Shares:	  	25,000,000        
		
	Total Exercise Price:	  	USD $ 250,000,000
		
	Type of Option:	  	Nonstatutory Stock Option
		
	Expiration Date:	  	March 8, 2031
		
	Vesting/Exercise Schedule:	  	This Option may be exercised, in whole or in part, at any time after the Option has vested in accordance with the vesting schedule set forth in Exhibit A. The actual number of Shares subject to the Option that vest, if any,
may be lower than the Total Number of Shares set forth above depending on the extent to which the Shares subject to the Option vest pursuant to a performance-based vesting condition and other conditions set forth in Exhibit A.

 By accepting this Option (whether electronically or otherwise), Participant acknowledges and
agrees to the following: 
 1. This Option is governed by the terms and conditions of this Award Agreement and the Plan. In the event of a
conflict between the terms of the Plan and this Award Agreement, the terms of the Plan will prevail. Capitalized terms used and not defined in this Award Agreement and the Notice of Grant will have the meaning set forth in the Plan. 

2. Participant has received a copy of the Plan, the Award Agreement and any Insider Trading Policy and represents that Participant has read
these documents and is familiar with their terms. Participant further agrees to accept as binding, conclusive, and final all decisions and interpretations of the Administrator (or its delegees) regarding any questions relating to this Option and the
Plan. 
 3. Vesting of the Option is subject to Participant’s continuous status in specified roles, as set forth in Exhibit A to
this Award Agreement, which is for an unspecified duration and Participant’s employment may be terminated at any time, with or without Cause, and nothing in the Award Agreement or the Plan changes the nature of that relationship. 

4. The Company is not providing any tax, legal, or financial advice, nor is the Company making any recommendations regarding participation in
the Plan. Participant should consult with his or her own personal tax, legal, and financial advisors regarding participation in the Plan before taking any action related to the Plan. 

5. Participant consents to electronic delivery and participation as set forth in the Plan and the Award Agreement. 

 

					
	PARTICIPANT:	 		 	VIEW, INC.
			
	   
	 		 	   

	Rao Mulpuri	 		 	By:
		 		 	Title:

  
 -2- 

 VIEW, INC. 

2021 CHIEF EXECUTIVE OFFICER INCENTIVE PLAN 

STOCK OPTION AGREEMENT 

1. Grant of Option. The Company hereby grants to the individual (the “Participant”) named in the Notice of
Stock Option Grant (the “Notice of Grant”) an option (the “Option”) under the View, Inc. 2021 Chief Executive Officer Incentive Plan (the “Plan”) to purchase the number of
Shares set forth in the Notice of Grant, at the exercise price per Share set forth in the Notice of Grant (the “Exercise Price”), subject to all of the terms and conditions set forth in the Notice of Grant, this Stock Option
Agreement, including Exhibit A attached hereto (the “Award Agreement”) and the Plan, which is incorporated herein by reference. If there is a conflict between the terms and conditions of the Plan and the terms and
conditions of this Award Agreement, the terms and conditions of the Plan will prevail. 
 2. Vesting Schedule. Except as provided in
Section 3, the Option awarded by this Award Agreement will vest in accordance with the vesting provisions set forth in the Notice of Grant and Exhibit A hereto. Options scheduled to vest on a certain date or upon the occurrence of a
certain condition will not vest in accordance with any of the provisions of this Award Agreement, unless Participant continuously serves in the roles set forth in Exhibit A hereto from the Date of Grant until the date such vesting occurs.

 3. Exercise of Option. 

(a) Right to Exercise. This Option may be exercised only within the term set forth in the Notice of Grant and may be exercised during
such term only in accordance with the Plan and the vesting terms of this Award Agreement, including Exhibit A hereto. 
 (b)
Method of Exercise. This Option is exercisable by delivery of an exercise notice, in the form attached as Exhibit A (the “Exercise Notice”) or in a manner and pursuant to such procedures as the Administrator may
determine, which will state the election to exercise the Option, the number of Shares in respect of which the Option is being exercised (the “Exercised Shares”), and such other representations and agreements as may be
required by the Company pursuant to the provisions of the Plan. The Exercise Notice will be completed by Participant and delivered to the Company. The Exercise Notice will be accompanied by payment of the aggregate Exercise Price as to all Exercised
Shares together with any Tax-Related Items (as defined below) required to be withheld, paid or provided pursuant to any Applicable Laws. This Option will be deemed to be exercised upon receipt by the Company
of such fully executed Exercise Notice accompanied by such aggregate Exercise Price and any other requirements or restrictions that may be imposed by the Company to comply with Applicable Laws or facilitate administration of the Plan.
Notwithstanding the above, Participant understands that the Applicable Laws of the country in which Participant is residing or working at the time of grant, vesting, and/or exercise of this Option (including any rules or regulations governing
securities, foreign exchange, tax, labor or other matters) may restrict or prevent exercise of this Option, and neither the Company nor any Parent or Subsidiary assumes any liability in relation to this Option in such case. 

4. Method of Payment. Payment of the aggregate Exercise Price will be by any of the following, or a combination thereof, at the
election of Participant unless otherwise specified by the Company in its sole discretion: 
 (a) cash (U.S. dollars); 

(b) check (denominated in U.S. dollars); 

  
 -3- 

 (c) consideration received by the Company under a cashless exercise program implemented by
the Company in connection with the Plan; or 
 (d) if Participant is subject to Section 16 of the Exchange Act, Participant may direct
the Company to withhold Shares to be issued upon exercise of the Option to pay the aggregate Exercise Price. 
 Participant understands and
agrees that, unless otherwise permitted by the Company, any cross-border remittance made to exercise this Option or transfer proceeds received upon the sale of Shares must be made through a locally authorized financial institution or registered
foreign exchange agency and may require the Participant to provide such entity with certain information regarding the transaction. 
 5.
Tax Obligations. 
 (a) Withholding of Taxes. Regardless of any action the Company or Participant’s employer (the
“Employer”) takes with respect to any or all applicable national, local, or other tax or social contribution, withholding, required deductions, or other payments, if any, that arise upon the grant, vesting, or exercise of
this Option, the holding or subsequent sale of Shares, and the receipt of dividends, if any, or otherwise in connection with this Option or the Shares (“Tax-Related Items”), Participant
acknowledges and agrees that the ultimate liability for all Tax-Related Items legally due by Participant is and remains Participant’s responsibility and may exceed any amount actually withheld by the
Company or the Employer. Participant further acknowledges and agrees that Participant is solely responsible for filing all relevant documentation that may be required in relation to this Option or any
Tax-Related Items (other than filings or documentation that is the specific obligation of the Company, an affiliate or Employer pursuant to Applicable Laws) such as but not limited to personal income tax
returns or reporting statements in relation to the grant, vesting or exercise of this Option, the holding of Shares or any bank or brokerage account, the subsequent sale of Shares, and the receipt of any dividends. Participant further acknowledges
that the Company and the Employer (a) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Option, including the grant, vesting, or
exercise of the Option, the subsequent sale of Shares acquired under the Plan and the receipt of dividends, if any; and (b) does not commit to and is under no obligation to structure the terms of the Option or any aspect of the Option to reduce
or eliminate Participant’s liability for Tax-Related Items, or achieve any particular tax result. Participant also understands that Applicable Laws may require varying Share or Option valuation methods
for purposes of calculating Tax-Related Items, and the Company assumes no responsibility or liability in relation to any such valuation or for any calculation or reporting of income or Tax-Related Items that may be required of Participant under Applicable Laws. Further, if Participant has become subject to tax in more than one jurisdiction between the date of grant and the date of any relevant
taxable event, Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction. 

(b) Satisfaction of Tax-Related Items. As a condition to the grant, vesting and exercise of
this Option and as set forth in Section 11 of the Plan, Participant hereby agrees to make adequate provision for the satisfaction of (and will indemnify the Company and any affiliate for) any Tax-Related
Items. No payment will be made to Participant (or his or her estate or beneficiary) related to an Option, and no Shares will be issued pursuant to an Option, unless and until satisfactory arrangements (as determined by the Company) have been made by
Participant with respect to the payment of any Tax-Related Items obligations of the Company and/or any Parent, Subsidiary, or Employer with respect to the grant, vesting or exercise of the Option. In this
regard, Participant authorizes the Company and/or any affiliate or Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a
combination of the following: 

  
 -4- 

 (i) withholding from Participant’s wages or other cash compensation paid to
Participant by the Company or the Employer; 
 (ii) withholding from proceeds of the sale of Shares acquired upon exercise of the Option,
either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant’s behalf pursuant to this authorization); or 

(iii) withholding in Shares to be issued upon exercise of the Option. 

Notwithstanding the foregoing, if Participant is subject to Section 16 of the Exchange Act, Participant may direct the Company to
withhold Shares to be issued upon exercise of the Option to satisfy Participant’s obligations with regard to all Tax-Related Items. 

If the obligation for Tax-Related Items is satisfied by withholding Shares, the Participant is deemed
to have been issued the full number of Shares purchased for tax purposes, notwithstanding that a number of Shares is held back solely for the purpose of paying the Tax- Related Items due as a result of the
Participant’s participation in the Plan. Participant shall pay to the Company or a Parent, Subsidiary, or Employer any amount of Tax-Related Items that the Company may be required to withhold, pay or
otherwise provide for as a result of Participant’s participation in the Plan that cannot be satisfied by one or more of the means previously described in this Section 5. Participant acknowledges and agrees that the Company may refuse to
honor the exercise and refuse to issue or deliver the Shares or the proceeds of the sale of Shares if Participant fails to comply with his or her obligations in connection with the Tax-Related Items. 

(c) Code Section 409A (Applicable Only to Participants Subject to U.S. Taxes). Under Code Section 409A,
an option that is granted with a per Share exercise price that is determined by the Internal Revenue Service (the “IRS”) to be less than the Fair Market Value of a Share on the date of grant (a “Discount
Option”) may be considered “deferred compensation.” A Discount Option may result in (i) income recognition by Participant prior to the exercise of the option, (ii) an additional twenty percent (20%) federal income
tax, and (iii) potential penalty and interest charges. The Discount Option may also result in additional state income, penalty and interest charges to the Participant. Participant acknowledges that the Company cannot and has not guaranteed that
the IRS will agree that the per Share exercise price of this Option equals or exceeds the Fair Market Value of a Share on the Date of Grant in a later examination. Participant agrees that if the IRS determines that the Option was granted with a per
Share exercise price that was less than the Fair Market Value of a Share on the date of grant, Participant will be solely responsible for Participant’s costs related to such a determination. 

6. Rights as Stockholder. Neither Participant nor any person claiming under or through Participant will have any of the rights or
privileges of a stockholder of the Company in respect of any Shares unless and until such Shares will have been issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). After
such issuance, Participant will have all the rights of a stockholder of the Company with respect to voting such Shares and receipt of dividends and distributions on such Shares, but prior to such issuance, Participant will not have any rights to
dividends and/or distributions on such Shares. 
 7. No Guarantee of Continued Service or Grants. PARTICIPANT ACKNOWLEDGES AND AGREES
THAT THE VESTING OF SHARES PURSUANT TO THE VESTING SCHEDULE HEREOF SHALL OCCUR ONLY BY CONTINUING AS A SERVICE PROVIDER IN THE ROLES SPECIFIED HEREIN AT THE WILL OF THE EMPLOYER OR CONTRACTING ENTITY (AS APPLICABLE) AND NOT THROUGH THE ACT OF BEING
HIRED, BEING GRANTED THE OPTION OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AWARD AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING 

  
 -5- 

 
SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND WILL NOT INTERFERE
IN ANY WAY WITH PARTICIPANT’S RIGHT OR THE RIGHT OF THE EMPLOYER OR THE COMPANY (OR ANY AFFILIATE) TO TERMINATE PARTICIPANT’S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE (SUBJECT TO APPLICABLE LAWS). 

8. Nature of Grant. In accepting the Option, Participant acknowledges, understands and agrees that: 

(a) the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated
by the Company at any time; 
 (b) the grant of the Option is voluntary and occasional and does not create any contractual or other right to
receive future grants of Options, or benefits in lieu of Options even if Options have been granted repeatedly in the past; 
 (c) all
decisions with respect to future awards of Options, if any, will be at the sole discretion of the Company; 
 (d) Participant’s
participation in the Plan is voluntary; 
 (e) the Option and the Shares subject to the Option are extraordinary items that do not
constitute regular compensation for services rendered to the Company or the Employer, and that are outside the scope of Participant’s employment contract, if any; 

(f) the Option and the Shares subject to the Option are not intended to replace any pension rights or compensation; 

(g) the Option and the Shares subject to the Option are not part of normal or expected compensation or salary for any purposes, including, but
not limited to, calculating any severance, resignation, termination, redundancy, dismissal, or end of service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments and in no event should be considered
as compensation for, or relating in any way to, past services for the Company or the Employer, subject to Applicable Laws; 
 (h) the future
value of the underlying Shares is unknown and cannot be predicted with certainty; further, if Participant exercises the Option and obtains Shares, the value of the Shares acquired upon exercise may increase or decrease in value, even below the
Exercise Price; 
 (i) Participant also understands that neither the Company nor any affiliate is responsible for any foreign exchange
fluctuation between local currency and the United States Dollar or the selection by the Company or any affiliate in its sole discretion of an applicable foreign currency exchange rate that may affect the value of the Option (or the calculation of
income or Tax-Related Items thereunder); 
 (j) in consideration of the grant of the Option, no
claim or entitlement to compensation or damages shall arise from forfeiture of the Option resulting from termination of employment by the Employer (for any reason whatsoever and whether or not in breach of Applicable Laws, including, without
limitation, applicable local labor laws), and Participant irrevocably releases the Employer from any such claim that may arise; if, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen,
Participant shall be deemed irrevocably to have waived his or her entitlement to pursue such claim; and 

  
 -6- 

 (k) the Option and the benefits under the Plan, if any, will not automatically transfer to
another company in the case of a merger, take-over or transfer of liability. 
 9. No Advice Regarding Grant. The Company is not
providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant’s participation in the Plan, or Participant’s acquisition or sale of the underlying Shares. Participant is hereby advised to
consult with his or her own personal tax, legal and financial advisors regarding Participant’s participation in the Plan before taking any action related to the Plan. 

10. Data Privacy. Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or
other form, of Participant’s Personal Data (as described below) by and among, as applicable, the Company, any affiliate or third parties as may be selected by the Company for the exclusive purpose of implementing, administering and managing
Participant’s participation in the Plan. Participant understands that refusal or withdrawal of consent will affect Participant’s ability to participate in the Plan; without providing consent, Participant will not be able to participate in
the Plan or realize benefits (if any) from the Option. 
 Participant understands that the Company and any affiliate, or
designated third parties may hold personal information about Participant, including, but not limited to, Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary,
nationality, job title, any shares of stock or directorships held in the Company or any affiliate, details of all Options or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant’s favor
(“Personal Data”). Participant understands that Personal Data may be transferred to any affiliate or third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in
the United States, Participant’s country (if different than the United States), or elsewhere, and that the recipient’s country may have different data privacy laws and protections than Participant’s country. In particular, the Company
may transfer Personal Data to the broker or stock plan administrator assisting with the Plan, to its legal counsel and tax/accounting advisor, and to the affiliate or entity that is Participant’s employer and its payroll provider. 

Participant should also refer to any data privacy policy implemented by the Company (which will be available to Participant separately
and may be updated from time to time) for more information regarding the collection, use, storage, and transfer of Participant’s Personal Data. 

11. Address for Notices. Any notice to be given to the Company under the terms of this Award Agreement will be addressed to the
Company, in care of its Secretary at View, Inc., 195 S. Milpitas Blvd, Milpitas, CA 95035, or at such other address as the Company may hereafter designate in writing. 

12. Non-Transferability of Option. This Option may not be transferred in any manner otherwise
than by will or by the laws of descent or distribution and may be exercised during the lifetime of Participant only by Participant. 
 13.
Binding Agreement. Subject to the limitation on the transferability of this Option contained herein, this Award Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of
the parties hereto. 
 14. Additional Conditions to Issuance of Stock. If at any time the Company will determine, in its discretion,
that the listing, registration, qualification or compliance of the Shares upon or with any securities exchange or under any Applicable Laws, the tax code and related regulations or the consent or approval of any governmental regulatory authority is
necessary or desirable as a condition to the grant or vesting of the Option or purchase by, or issuance of Shares to, Participant (or his or her estate) hereunder, such purchase or issuance 

  
 -7- 

 
will not occur unless and until such listing, registration, qualification, compliance, consent or approval will have been completed, effected or obtained free of any conditions not acceptable to
the Company. The Company will make all reasonable efforts to meet the requirements of any Applicable Laws. Assuming such compliance, for purposes of the Tax-Related Items, the Exercised Shares will be
considered transferred to Participant on the date the Option is exercised with respect to such Exercised Shares. The Company shall not be obligated to issue any Shares pursuant to this Option at any time if the issuance of Shares, or the exercise of
an Option by Participant, violates or is not in compliance with any Applicable Laws. 
 15. Plan Governs. This Award Agreement is
subject to all terms and provisions of the Plan. If there is a conflict between one or more provisions of this Award Agreement and one or more provisions of the Plan, the provisions of the Plan will govern. Capitalized terms used and not defined in
this Award Agreement and in the Notice of Grant will have the meaning set forth in the Plan. 
 16. Administrator Authority. The
Administrator will have the power to interpret the Plan and this Award Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules
(including, but not limited to, the determination regarding whether any Shares subject to the Option have vested). All actions taken, and all interpretations and determinations made, by the Administrator in good faith will be final and binding upon
Participant, the Company and all other interested persons. No member of the Administrator will be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or this Award Agreement. 

17. Electronic Delivery and Acceptance. By accepting this Option, Participant agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company, and consents to the electronic delivery of the Award Agreement, the Plan, account statements, Plan
prospectuses, and all other documents, communications, or information related to the Option and current or future participation in the Plan. Electronic delivery may include the delivery of a link to the Company intranet or the internet site of a
third party involved in administering the Plan, the delivery of the document via e-mail, or such other delivery determined at the Company’s discretion. Participant may receive from the Company a paper
copy of any documents delivered electronically at no cost if Participant contacts the Company by telephone, through a postal service, or electronic mail to Stock Administration. 

18. Translation. If Participant has received this Award Agreement, including appendices, or any other document related to the Plan
translated into a language other than English, and the meaning of the translated version is different than the English version, the English version will control. 

19. Imposition of Other Requirements. The Company reserves the right to impose other requirements on Participant’s participation
in the Plan, on the Option and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with any Applicable Laws or facilitate the administration of the Plan, and to require
Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. Furthermore, Participant understands that the Applicable Laws of the country in which he or she is resident at the time of grant,
vesting, and/or exercise of this Option or the holding or disposition of Shares (including any rules or regulations governing securities, foreign exchange, tax, labor or other matters) may restrict or prevent exercise of this Option or may subject
Participant to additional procedural or regulatory requirements he or she is solely responsible for and will have to independently fulfill in relation to this Option or the Shares. Notwithstanding any provision herein, this Option and any Exercised
Shares shall be subject to any special terms and conditions or disclosures as set forth in the Company’s bylaws, including any restrictions on the disposition of Shares acquired under the Plan. Participant also understands and agrees that if he
or she works, resides, moves to, or otherwise is or becomes subject to Applicable Laws or company policies of another jurisdiction at any time, certain country-specific notices, disclaimers and/or terms and conditions may apply to him or her as from
the date of grant, unless otherwise determined by the Company in its sole discretion. 

  
 -8- 

 20. Captions. Captions provided herein are for convenience only and are not to serve
as a basis for interpretation or construction of this Award Agreement. 
 21. Agreement Severable. If any provision in this Award
Agreement will be held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of this Award Agreement. 

22. Modifications to the Award Agreement. This Award Agreement constitutes the entire understanding of the parties on the subjects
covered. Participant expressly warrants that he or she is not accepting this Award Agreement in reliance on any promises, representations, or inducements other than those contained herein. Modifications to this Award Agreement or the Plan can be
made only in an express written contract executed by a duly authorized officer of the Company. Notwithstanding anything to the contrary in the Plan or this Award Agreement, the Company reserves the right to revise this Award Agreement as it deems
necessary or advisable, in its sole discretion and without the consent of Participant, to comply with Code Section 409A or to otherwise avoid imposition of any additional tax or income recognition under Code Section 409A in connection to
this Option. 
 23. Amendment, Suspension or Termination of the Plan. By accepting this Award, Participant expressly warrants that he
or she has received an Option under the Plan, and has received, read and understood a description of the Plan. Participant understands that the Plan is discretionary in nature and may be amended, suspended or terminated by the Company at any time.

 24. Governing Law and Venue. This Award Agreement will be governed by the laws of the State of Delaware, without giving effect to
the conflict of law principles thereof. For purposes of litigating any dispute that arises under this Award or this Award Agreement, the parties hereby submit to and consent to the jurisdiction of the State of Delaware, and agree that such
litigation will be conducted in the courts of Santa Clara County, California, or the federal court in San Francisco, California, and no other courts. 

*** 

  
 -9- 

 EXHIBIT A 

VESTING SCHEDULE 

As used in this Exhibit A, the following definitions shall apply to the following capitalized terms: 

“Achievement Date” means the first trading date occurring during the Performance Period in which a Company Stock Price Target
is achieved and certified by the Board (or a committee delegated by the Board) as having been met. 
 “Company Stock Price”
means the trailing average trading price of a Share on the Nasdaq stock exchange (or other national securities exchange on which the Shares are then listed) measured over any consecutive sixty
(60) calendar-day period, as reported by, or based upon data reported by a reliable reporting service as determined by the Company. In case of any dispute as to the determination of the Company Stock
Price, the Administrator shall have the sole discretion to make the final determination. 
 “Company Stock Price Target”
means each target with respect to the Company Stock Price as set forth in Table 1 under Section 2 of this Exhibit A, which shall be subject to equitable adjustment by the Administrator to account for a stock split, reverse stock
split, stock dividend, combination, consolidation, recapitalization or reclassification of the Common Stock, subdivision of the Common Stock, a rights offering, a reorganization, merger, spin-off, split-up, repurchase, or exchange of the Common Stock or other securities of the Company, other significant corporate transaction, or any other change affecting the Common Stock. 

“Performance Period” means the period commencing on March 8, 2021 and ending on March 8, 2031. 

“Service Condition” means Participant continuously holding the title of either Chief Executive Officer of the Company or
Executive Chairman of the Company. 
  

	 	1.	 Performance-Based Option. The number of Shares subject to the Option that will vest will be
determined based upon the achievement of Company Stock Price Targets during the Performance Period and the satisfaction of the Service Condition as of each applicable Achievement Date, all in accordance with this Exhibit A.

  

	 	2.	 Vesting Condition. As detailed in Table 1, below, the Option is divided into ten
(10) tranches (each, a “Tranche”), with each Tranche representing one-tenth (1/10th) of the Shares subject to the Option. Shares shall vest and become exercisable upon satisfaction of the
Company Stock Price Target set forth next to the applicable Tranche in Table 1, subject to Participant continuing to satisfy the Service Condition through the applicable Achievement Date. The determination of the number of Shares vested based
on an applicable Company Stock Price Target shall not be determined through linear interpolation. The Company Stock Price must be at or above the Company Stock Price Target specified in Table 1, below, for the number of Shares specified next
to such Company Stock Price Target to vest and become exercisable. For the avoidance of doubt, (a) each Company Stock Price Target may only be achieved once during the Performance Period and (b) more than one Company Stock Price Target may
be achieved on a particular date. 

  

	 	a.	 Table 1: Award Vesting Milestones. 

 

				                                       
           				                                       
           	
	 Tranche
	  	Company Stock Price Target	 	  	Shares	 
	 1
	  	$	20.00	 	  	 	2,500,000	 
	 2
	  	$	30.00	 	  	 	2,500,000	 
	 3
	  	$	40.00	 	  	 	2,500,000	 

				                                       
           				                                       
           	
	 4
	  	$	50.00	 	  	 	2,500,000	 
	 5
	  	$	60.00	 	  	 	2,500,000	 
	 6
	  	$	70.00	 	  	 	2,500,000	 
	 7
	  	$	80.00	 	  	 	2,500,000	 
	 8
	  	$	90.00	 	  	 	2,500,000	 
	 9
	  	$	100.00	 	  	 	2,500,000	 
	 10
	  	$	100.00	 	  	 	2,500,000	 

  

	 	3.	 Service Condition and Forfeiture. In the event of Participant’s failure to satisfy the
Service Condition at any time, any Shares subject to the Option that remain then-unvested as of such date shall be forfeited and Participant shall have no further rights with respect to such Shares, and any vested Shares subject to the Option shall
remain outstanding and exercisable for twelve (12) months; provided that for so long as Participant is still employed at the Company in a role other than as the Company’s Chief Executive Officer or Executive Chairman, any vested Shares
subject to the Option shall remain outstanding and exercisable, up to the Expiration Date. No accelerated vesting shall occur as a result of Participant’s termination of employment for any reason, including by reason of death or disability.

  

	 	4.	 Change in Control Treatment of Milestones. Notwithstanding anything in the Plan or the Award
Agreement, including this Exhibit A, to the contrary, in the event that a Change in Control occurs while Participant satisfies the Service Condition, “Company Stock Price” will mean the price per share applicable to the Change in
Control for the purpose of determining whether any additional Company Stock Price Targets are achieved as of the date of the Change in Control. If the price per share applicable to the Change in Control equals or exceeds an applicable Company Stock
Price Target, then the number of Shares specified next to such Company Stock Price Target shall vest and become exercisable immediately prior to the effective time of the Change in Control . Upon a Change in Control, any vested portion of the Option
will be assumed or substituted by the Company’s successor and any unvested portion of the Option will automatically terminate as of the effective time of the Change in Control unless otherwise agreed at the time of the Change in Control. The
vested and unexercised portion of the Option as of the date of the Change in Control (after giving effect to any vesting that occurs on the date of the Change in Control as described in this Section 4) shall remain exercisable through the
Expiration Date. 

  

	 	5.	 Post-Exercise Holding Period. Participant shall retain and hold any Shares acquired upon exercise
of the Option for a period of at least eighteen (18) months, measured from the date such Shares vested. 

  
 -2-Exhibit 10.1

 

EMPLOYMENT
AGREEMENT

 

This Employment Agreement (“Agreement”)
made and entered into effective as of the 19th day of March 2021 (the “Effective Date”) by and between J. Melville
Engle, an individual, residing at 8778 E. 152nd Place, Thornton, CO 80602 (“Employee”), and Predictive Oncology Inc.,
2915 Commers Drive, Suite 900, Eagan, Minnesota 55121, a Delaware corporation (“Company”), collectively referred to
as “the Parties”.

 

WITNESSETH:

 

WHEREAS, the Company desires
to employ Employee to render services for the Company as its Chief Executive Officer on the terms and conditions hereinafter set
forth, and Employee desires to be employed by the Company on such terms and conditions;

 

WHEREAS, Employee began employment
with the Company on March 19, 2021, after Employee had accepted the terms of an Offer Letter dated March 19, 2021 but before he
executed this Agreement;

 

WHEREAS, Employee agreed to
begin his employment understanding and acknowledging that his employment was conditioned upon signing this Agreement.

 

NOW, THEREFORE, in consideration
of the promises and of the mutual covenants and agreements contained herein, the Parties hereby agree as follows:

 

1.                 
Employee’s Acknowledgment and Certifications. Employee hereby represents and certifies that Employee is not subject to
any other agreement or restrictive covenant that Employee violates by working with the Company. Further, Employee represents that
no conflict of interest or breach of Employee’s fiduciary duties will result by working with and performing duties for the
Company. Employee further agrees and certifies that Employee will not use or disclose to the Company any confidential, proprietary
or trade secret information belonging to another individual or entity which may not properly be used or disclosed by Employee to
the Company.

 

2.                 
Employment and Term. The Company and Employee acknowledge that Employee has been serving as Chairman of the Board of Directors
of the Company since January 2020 and has been a member of the Board of Directors of the Company since October 2016. The Company
hereby employs Employee and Employee hereby accepts employment with the Company upon the terms and conditions of this Agreement.
Employee’s employment with the Company is at-will and commenced on March 19, 2021. This Agreement does not modify the at-
will nature of Employee’s employment nor is it intended to guarantee Employee a specific term of employment with the Company.
Either Employee or the Company may terminate the employment relationship at any time, for any lawful reason. Employee agrees to
abide by all Company rules, policies, and procedures.

 

3.                 
Duties. Employee shall have the title of Chief Executive Officer and shall maintain the position of Chairman of the Board
at the discretion of the Board of Directors of the Company (the “Board”) or until such earlier date the Employee
decides to relinquish the Chairman position. Employee will devote Employee’s full working time, attention, loyalty,
skills and efforts to diligently perform all the duties, responsibilities, and requirements assigned to Employee while
employed by the Company. The Company and Employee acknowledge that Employee resides in Thornton, CO and will travel on
business matters to the Company’s offices and elsewhere at Company expense, as needed, using business/first class
airfare. Employee’s title, position and duties are at all times subject to change at the Company’s sole
discretion. Employee will be limited to holding board seats for a maximum of two public companies in addition to the Company
as long as there is no conflict or interference with Employee’s obligations to the Company.

 

    1

     

    

 

		4.	Compensation.

 

		a.	Base Salary. Employee will receive an initial annualized base salary of $475,000 (gross, less applicable legally required
withholdings and such other deductions as Employee voluntarily authorizes in writing). In addition, Employee will receive (i) regular
Board and Committee fees from the Effective Date through December 31, 2021, as set forth in the Director Compensation Program effective
January 1, 2021 (the “Program”) and (ii) additional compensation of $5,835 to cover tax liability on compensation as
Chairman, as provided in the Program. As provided in the Program, commencing January 1, 2022, Employee will not receive additional
compensation for service on the Board or committees of the Board or service as Chairman. Employee’s base salary and other
compensation will be subject to review and adjustment by the Company at any time, as the Company deems appropriate; provided, that
Employee’s base salary will not be reduced without Employee’s consent unless a salary reduction is imposed upon substantially
all employees of the Company as part of a general reduction.

 

		b.	Bonus and Incentive Compensation. For each calendar year during the
term of this Agreement, beginning at date of hire in 2021, Employee shall be eligible to receive an annual incentive bonus determined
annually at the discretion of the Compensation Committee of the Board. The Compensation Committee will award a bonus based on performance
of Employee vs. annual MBO/Objectives on a percentage of base salary. The Compensation Committee will be the evaluator of Employee
performance and will make the final decision on the bonus amount. Bonus payout will range from 0% to 50% of base salary, or at
the Board’s discretion, a higher percentage based on performance. Any bonus payments made under this Section 4(b) shall be
paid within 2 1/2 months of the end of the bonus period, provided that Employee was employed by the Company on the last day of
the bonus period.

 

Employee will also be eligible to participate in
a long-term incentive plan to be adopted and maintained by the Compensation Committee, with the current long-term incentive plan
attached to this Agreement as Exhibit A.

 

Employee will also be considered for stock option awards
in connection with grants to key employees and in other appropriate circumstances.

Any grants of equity awards, including those above,
will be made from the Company’s Amended and Restated 2012 Stock Incentive Plan (the “2012 Plan”) or successor
plans. There must be sufficient shares available under the plan reserve for any of these grants, meaning that some of these grants
may be subject to obtaining shareholder approval of an increase to the plan reserve.

 

    2

     

    

 

		c.	Directors & Officers Insurance. While employed by the Company,
Employee shall be considered an officer of the Company and shall be covered by D&O Insurance, or any other similar type of
insurance, that provides coverage for Employee’s acts or omissions undertaken during the course and scope of Employee’s
employment, and maintain coverage for Employee for at least three (3) years following Employee’s employment.

 

		5.	Additional Benefits.

 

		a.	Automobile. The Company shall reimburse Employee for deductible automobile
mileage according to its Expense Reporting Procedures.

 

		b.	Business Expenses. The Company will reimburse Employee for all reasonable,
deductible and substantiated business expenses per its Expense Reporting Procedures. This includes, but is not limited to, such
expenses as computer and necessary software, cell phones and business meetings.

 

		c.	Vacation. Employee shall be entitled to five (5) weeks of paid vacation
per each calendar year earned ratably over each calendar year, to be taken at such times as Employee and the Company shall determine
and provided that no vacation time shall unreasonably interfere with the duties required to be rendered by Employee hereunder.
Any vacation time not taken by Employee during any calendar year may be carried forward into one succeeding calendar year. Accrued
but unused vacation will be paid out to Employee at the time of termination of employment.

 

		d.	Benefits. Employee will be eligible to participate in other benefits
programs generally available to executive officers of the Company specifically including health and dental insurance, short-term
and long-term disability insurance, life insurance and the 401(k) plan.

 

6.                 
Non-Competition. Employee agrees that while employed by the Company and for a period of twelve (12) months after the date Employee’s
employment with the Company terminates, regardless of the reason for termination, Employee will not, without the prior written
consent of the Company, directly or indirectly, as an employee, owner, consultant or in any other capacity whatsoever, for Employee’s
own behalf or on behalf of any other person or entity, anywhere in the United States of America:

 

		a.	Prohibition on Competition. Engage in or render services, directly
or indirectly, to any person or organization engaged in or about to become engaged in the development, production, marketing or
selling of any product, process or service in existence or under
development which is similar to or competes with a product, process or service of the Company; or

 

    3

     

    

 

		b.	Company Clients. Work or perform services as an employee, agent,
independent contractor or otherwise, for any client, customer, supplier or business partner of the Company with whom Employee worked,
solicited, marketed or obtained confidential information about during Employee’s employment with the Company; or

 

		c.	Non-Solicitation. (i) Solicit, contact, sell to, provide services
to, or attempt to divert, take away or induce clients or prospective clients of the Company with whom Employee worked, solicited,
marketed, or obtained confidential information about during Employee’s employment with the Company, regarding services or
products that are competitive with any of the Company’s services or products; or (ii) solicit, divert, take away or induce
any employee or independent contractor of the Company to leave the employ or service of the Company.

 

The Company is providing Employee with adequate and
valuable consideration to compensate Employee for the reasonable restrictions on Employee’s post-employment competitive activities
contained within this Agreement. Employee hereby acknowledges that Employee’s employment with the Company that began on March
19, 2021, and the benefits associated with that, the Employee’s stock option grant and access to certain of the Company’s
proprietary information and goodwill, constitute adequate and sufficient consideration for the restrictive covenants in this Agreement.
Employee agrees that the restrictions set forth in this Agreement are reasonable considering Employee’s position.

 

If any of the above restrictions are deemed by a court
of competent jurisdiction to be unreasonable in duration or in geographical scope, it will be considered modified and valid for
such duration and geographical scope as the court determines to be reasonable under the circumstances. The duration of the above
restrictions will be extended beyond the twelve (12) month period for a period equal to the duration of any breach or default of
such covenant by Employee. Upon terminating employment with the Company (for whatever reason), Employee has an affirmative obligation
to inform any prospective employer and/or actual employer, of Employee’s post-employment obligations contained within this
Agreement including Employee’s non-competition and non-solicitation obligations.

 

    4

     

    

 

7.                 
Intellectual Property. Employee agrees that all rights, title and interest of every kind and nature whatsoever, whether
now known or unknown, in and to any “Intellectual Property,” defined to include, but not be limited to, any
patent rights, trademarks, copyrights, ideas, creations and properties invented, created, written, developed, furnished,
produced or disclosed by Employee in the course of rendering his/her services to the Company (both before the execution of
this Agreement and thereafter) shall, as between the Parties, be and remain the sole and exclusive property of the Company
for any and all purposes and uses whatsoever, and Employee shall have no right, title or interest of any kind or nature
therein or thereto, or in and to any results and proceeds there from. Employee agrees to assign, and hereby expressly and
irrevocably assigns, to the Company all worldwide rights, title and interest, in perpetuity, in respect of any and all rights
Employee may have or acquire in the Intellectual Property. The assignment of the rights as above shall not lapse if the
Company has not exercised its rights under the assignment for any period of time or in any jurisdiction or territory.
Pursuant to Section 181.78 of the Minnesota Statutes, the preceding sentence does not apply to an invention for which no
equipment, supplies, facility or trade secret information of the Company was used and which was developed entirely on the
Employee’s own time, and (1) which does not relate (a) directly to the business of the Company or (b) to the
Company’s actual or demonstrably anticipated research or development, or (2) which does not result from any work
performed by Employee for the Company. To the extent any of the rights, title, and interest in and to the Intellectual
Property cannot be assigned to the Company (and to the extent any of Employee’s retained rights under Section 181.78
were incorporated by Employee (directly or indirectly) in any of the Company’s past, current or future products or
services), Employee hereby grants to the Company an exclusive, royalty-free, transferable, perpetual, irrevocable,
unrestricted, worldwide license (with rights to sublicense through one or more tiers of sublicense) to such non-assignable
(or non-assigned) rights. To the extent any rights, title and interest in and to Intellectual Property rights can be neither
assigned nor so licensed by Employee to the Company, Employee hereby irrevocably waives and agrees never to assert such
non-assignable and non-licensable rights, title and interest against the Company, any of the Company’s successors in
interest, and the customers and licensees of either. Further, Employee agrees to waive, and hereby waives, any “moral
rights” Employee may have or may obtain in the Intellectual Property. Employee further agrees to assist the Company in
every proper way to apply for, obtain, perfect and enforce rights in the Intellectual Property in any and all countries, and
to that end Employee will execute all documents for use in applying for, obtaining and perfecting such rights and enforcing
same, as the Company may desire, together with any assignments thereof to the Company or persons designated by it. Employee
appoints the Company as its attorney in fact to execute any documents necessary to achieve such results. To the maximum
extent possible, the Company shall be shown in all documentation as the owner of all rights in the Intellectual Property.

 

8.                 
Nondisclosure of Confidential Information. Employee shall keep confidential and not disclose to anyone or use, either during
or after Employee’s employment with the Company, any Confidential Information of the Company, except as required by Employee’s
employment with the Company or as expressly authorized in writing by the Company. For the purposes of this Agreement, “Confidential
Information” is any and all sensitive, confidential, proprietary and trade secret information concerning or relating to the
Company and its direct and indirect parents, subsidiaries and/or affiliated organizations, including any information or compilation
of information which derives independent economic value from not being generally known to and not being readily ascertainable by
proper means by other persons who can obtain economic value from its disclosure or use. Examples of Confidential Information not
to be disclosed or used except as expressly permitted by the Company include, but are not limited to, the following:

 

		a.	All patterns, compilations, programs, know how; designs, processes or
                                                            formulae; software; market or sales information or plans, devices, methods, concepts, techniques, processes, source codes,
                                                            data capture innovations, algorithms, user interface designs and database designs relating to the Company’s
products, services, systems or business;

 

    5

     

    

 

		b.	Information acquired or compiled by the Company concerning actual or potential
clients/customers, suppliers and business partners, including their identities, financial information concerning their actual or
prospective business operations, identity and quantity of services and/or products provided by the Company, and any unpublished
written materials furnished by or about them to the Company; and

 

		c.	Information concerning the Company’s ownership, management, financial
condition, financial operations, business activities or practices, sales activities, marketing activities or plans, research and
development, pricing practices, legal matters, and strategic business plans.

 

Employee acknowledges that the Company shall at all
times be and remain the owner of all Confidential Information disclosed to/acquired by Employee during Employee’s employment
with the Company, and Employee acknowledges that Employee may use the Confidential Information only for the limited purposes for
which it was disclosed under this Agreement. Employee shall use his/her best efforts to preserve the confidentiality of such Confidential
Information which he/she knows or reasonably should know the Company deems to be Confidential Information. Employee agrees that
he/she will not knowingly use, disclose or permit the use or disclosure of the Company’s Confidential Information in any
manner which may injure the Company’s business, impair its investments and goodwill, and/or adversely impact the Company’s
relationships with its actual or potential customers and suppliers. The obligations of this Section shall continue in full force
and effect after the termination of this Agreement and the termination of Employee’s employment with the Company. As used
in this Section 8, the “Company” shall include the Company and each of its direct and indirect parent, subsidiary and
affiliated organizations on a collective basis.

 

9.                 
Use, Removal, and Return of the Company’s Property. Employee shall not use, duplicate, disseminate or remove from the
Company’s premises any information contained in any records, documents, data, or other tangible items of the Company in original,
duplicate or copied form, except as needed in the ordinary course of performing his/her employment duties for and subject to the
approval by the Company. Employee shall immediately deliver to the Company, upon termination of Employee’s employment with
the Company, or at any other time upon the Company’s request, any records, documents, data, and other tangible items in Employee’s
possession or control belonging to or relating to the products, services, systems or business of the Company. Employee will not
retain any copies or reproductions of records, documents, data or other tangible items of the Company or any of its direct or indirect
parent, subsidiary or affiliated organizations.

 

10.             
Termination by Company for Cause. The Company may terminate Employee’s employment for “Cause” at any time,
without notice. For purposes of this Agreement, the term “Cause” shall mean any of the following:

 

		·	Employee engages in willful misconduct or fails to follow the reasonable
and lawful instructions of the Board of Directors, if such conduct is not cured within thirty (30) calendar days after the Company
sends notice to the Employee of the alleged Cause,

 

    6

     

    

 

		·	Employee embezzles or misappropriates assets of the Company or any of its
subsidiaries;

 

		·	Employee’s violation of Employee’s obligations in this Agreement,
if such conduct is not cured within thirty (30) calendar days after the Company sends written notice to the Employee of the alleged
Cause;

 

		·	Breach of any agreement between Employee and the Company or to which the
Company and Employee are parties, or a breach by Employee of a fiduciary duty or responsibility to the Company;

 

		·	The commission by Employee of fraud or other willful conduct that adversely
affects the business or reputation of the Company, as determined in the Company’s sole discretion; or,

 

		·	The Company has a reasonable belief Employee engaged in some form of harassment
or other improper conduct prohibited by the Company policy or the law.

 

In the event of a termination for Cause, Employee
shall only be entitled to receive payment of base salary, in effect at the time of termination, through Employee’s last date
of employment and accrued, unused vacation pay. Employee will not be entitled to any other payments, salary or bonus. Employee
shall have absolutely no right to receive or retain any other payment or compensation whatsoever under this Agreement. The Employee’s
rights and obligations regarding stock options, restricted stock or other equity incentives owned by Employee shall be determined
in accordance with and be governed by the 2012 Plan or other applicable equity plan.

 

11.             
Termination by the Company without Cause. The Company may terminate Employee’s employment without Cause at any
time, for any reason, without notice. In the event Employee’s employment is terminated by the Company without Cause,
Employee shall be entitled to receive payment of base salary, in effect at the time of termination, through Employee’s
last date of employment and accrued, unused vacation pay. In addition, Employee shall be entitled to receive from the Company
(a) severance pay in an amount equal to twelve (12) months of Employee’s base salary then in effect at the time of
termination, less applicable taxes and withholdings; and (b) bonus payment on a pro-rata basis through the date of
Employee’s termination. The severance pay and bonus payment provided in the preceding sentence is conditioned upon
Employee’s execution of a full and final waiver of all claims against the Company, and not rescinding or revoking (to
the extent permitted under such release) Employee’s release, in a form acceptable to the Company. The severance pay and
bonus payment will be paid to Employee in equal bimonthly installments over a period of 12 (twelve) months (or 24 pay
periods), with the first payment on the first payday following Employee’s execution of the release and the expiration
of any rescission and revocation periods provided in the release and subsequent payments on subsequent paydays.

 

    7

     

    

 

12.             
Termination by Employee for Good Reason. For purposes of this Agreement, “Good Reason” shall include (i) a
material diminution in Employee’s position, duties, base salary, and responsibilities; or (ii) the Company’s
notice to Employee that his or her position will be relocated to an office which is greater than 100 miles from
Employee’s prior office location. In all cases of Good Reason, Employee must have given notice to the Company that an
alleged Good Reason event has occurred and the circumstance must remain uncorrected by the Company after the expiration of
thirty (30) days after receipt by the Company of such notice. If Employee terminates his or her employment for Good Reason,
Employee shall be entitled to receive from the Company payment of base salary, in effect at the time of termination, through
Employee’s last date of employment and accrued, unused vacation pay. In addition, Employee shall be entitled to (a)
severance pay in an amount equal to twelve (12) months of Employee’s base salary then in effect at the time of
termination, less applicable taxes and withholdings; and (b) bonus payment on a pro-rata basis through the date of
Employee’s termination. The severance pay and bonus payment provided in the preceding sentence is conditioned upon
Employee’s execution of a full and final waiver of all claims against the Company, and not rescinding or revoking (to
the extent permitted under such release) Employee’s release, in a form acceptable to the Company. The severance pay and
bonus payment will be paid to the Employee in equal bimonthly installments over a period of 12 (twelve) months (or 24 pay
periods) with the first payment on the first payday following Employee’s execution of the release and the expiration of
any rescission and revocation periods provided in the release and subsequent payments on subsequent paydays.

 

13.             
Termination by Employee without Good Reason. If Employee terminates his or her employment with the Company without Good Reason,
Employee is only entitled to his or her base salary, then in effect at the time of termination, through Employee’s last day
of employment and accrued, unused vacation pay. Employee will not be entitled to any other payments, salary, or bonus.

 

14.             
Governing Law; Venue. This Agreement shall be governed by and construed in accordance with the laws of the State of Minnesota.
The venue for any action relating to this Agreement shall be the federal or state courts located in Dakota County, Minnesota, to
which venue each party hereby submits.

 

15.             
Notices. Any notice or other communication required or permitted hereunder shall be in writing and shall be deemed to have
been given, when received, if delivered by hand or by telegram, or three (3) working days after deposited, if placed in the mail
for delivery by certified mail, return receipt requested, postage prepaid and addressed to the appropriate party at the following
addresses:

 

	 	Company:	Predictive Oncology Inc.
	 	 	Attention: Bob Myers, CFO 2915 Commers Drive
	 	 	Suite 900
	 	 	Eagan, Minnesota 55121

 

    8

     

    

 

		Employee:	J. Melville Engle 
	 	 	8778 E. 152nd Place 
	 	 	Thornton, CO 80602

 

Addresses may be changed by written notice given pursuant
to this Section; however, any such notice shall not be effective, if mailed, until three (3) working days after depositing in the
mails or when actually received, whichever occurs first.

 

16.             
Other Agreements. This Agreement contains the entire agreement between the Parties concerning terms of employment and supersedes
at the effective date hereof any other agreement, written or oral, except the 2012 Plan or other applicable equity plans and the
applicable award agreements under such plans.

 

17.             
Modification and Waiver. A waiver by either party of a breach of any provision of this Agreement shall not operate as or be
construed as a waiver of any subsequent breach thereof. Any modification of this Agreement must be in writing and signed by both
parties.

 

18.             
Scope of Remedies. In the event Employee breaches the covenants contained in this Agreement, Employee recognizes that irreparable
injury will result to the Company, that the Company’s traditional remedies at law for damages will be inadequate, and that
the Company shall be entitled to injunctive relief ordered by a judicial court of competent jurisdiction to restrain the continuing
breach by Employee, Employee’s partners, agents, or employees, or any other persons or entities acting for or with Employee.
The Company shall further be entitled to seek remedies in a judicial court of competent jurisdiction for damages, reasonable attorney’s
fees, and all other costs and expenses incurred in connection with the enforcement of this Agreement, in addition to any other
rights and remedies which the Company may have at law or in equity.

 

19.             
Binding Effect, Assigns, Successors, Etc. The benefits and obligations of this Agreement shall inure to the successors and
assigns of the Company, to any person or entity which purchases substantially all of the assets of the Company, and to any subsidiary,
affiliated corporation, or operating division of the Company. This Agreement is not assignable by Employee.

 

20.             
Savings Clause. If any provision, portion or aspect of this Agreement is determined to be void, or voidable by any legislative,
judicial or administrative action as properly applied to this Agreement, then this Agreement shall be construed to so limit such
provision, portion or aspect thereof to render same enforceable to the greatest extent permitted by or in the relevant jurisdiction.

 

21.             
Headings. The headings of this Agreement are intended solely for convenience and reference, and shall give no effect in the
construction or interpretation of this Agreement.

 

22.             
Survival. The restrictions on Employee’s post-employment activities (including Employee’s confidentiality obligations
and restrictive covenants), and those sections of this Agreement that pertain to interpretation and enforcement of such restrictions,
will survive the termination of this Agreement and/or Employee’s employment and will remain in full force and effect.

 

    9

     

    

 

23.             
Execution. This Agreement may be executed in two (2) or more counterparts, and each such counterpart deemed an original, Original
signatures on copies of the Agreement transmitted by facsimile will be deemed originals for all purposes hereunder.

 

IN WITNESS WHEREOF, the parties hereto have caused
this Agreement to be executed effective as of the day and year first written above.

 

 

	 	PREDICTIVE ONCOLOGY INC.
	 	 	 
	 	By:	 
	 	Title:	CFO
	 	 	 
	 	 	 
	 	EMPLOYEE
	 	 
	 	By:	 
	 	Title:	Chief Executive Officer

 

    10

     

    

 

EXHIBIT A TO EMPLOYMENT AGREEMENT

 

Long Term Incentive Plan: Each
year, Employee will be granted Restricted Stock, with the program to be structured to reward performance and result in officer
retention. The annual Long-Term Incentive Plan (“LTIP”) awards will each vest after three years (rolling) subject to
continued employment, with the amount that vests to be based on two or more measures of employment performance, including shareholder
return (increase in common stock price and accomplishment of profit budgets).

 

Based on Employee performance, an
increased common stock price (goal established at the commencement of each year’s grant) and continued employment over a
3-year period:

 

		1.	Employee will be granted 100,000 Restricted Stock shares for each of the
fiscal years 2021, 2022 and 2023. The grant for 2021 will be made on or before May 1, 2021, with vesting based on performance for
2021, 2022 and 2023 and continued employment through January 1, 2024. The grants for 2022 and 2023 will be made on January 1 of
each such year, with vesting based on performance over a three year period and continued employment through the three year anniversary
of such grant.

 

		2.	These award amounts may be adjusted from year-to-year so that the targeted
values of LTIP awards represent the appropriate percentage of total compensation.

 

		3.	If advantageous for tax planning or other reasons, these awards may be restricted
stock units (RSUs) rather than Restricted Stock.

 

Any grants of equity awards, including
those above, will be made from the Company’s Amended and Restated 2012 Stock Incentive Plan (the “2012 Plan”)
or successor plans. There must be sufficient shares available under the plan reserve for any of these grants, meaning that some
of these grants may be subject to obtaining shareholder approval of an increase to the plan reserve. There are currently only 554,000
shares available under the 2012 Plan, meaning that the grants of the awards described above may not be made until shareholder approval
of an amendment to the 2012 Plan to increase the share reserve. If shareholder approval is necessary for the Restricted Stock or
RSU awards described above and is not obtained during the calendar year in which an award is required to be made, the Company may
pay a cash award of equivalent value.

 

 

 

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]